-
Views
-
Cite
Cite
L. Bernard, R. Stern, D. Lew, P. Hoffmeyer, Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram, Clinical Infectious Diseases, Volume 36, Issue 9, 1 May 2003, Page 1197, https://doi.org/10.1086/374558
- Share Icon Share
Abstract
Linezolid, a new synthetic antimicrobial, is an important weapon against methicillin-resistant Staphylococcus aureus (MRSA). Although there are reports of serotonin syndrome developing after concomitant use of linezolid and the selective serotonin reuptake inhibitor paroxitene, this report concerns a patient receiving citalopram who developed thrombocytopenia, serotonin syndrome, and lactic acidosis and died following long-term linezolid therapy.
© 2003 by the Infectious Diseases Society of America
Issue Section:
BRIEF REPORTS
You do not currently have access to this article.